Spontaneous Coronary Artery Dissection - AntipLatelet Therapy Intensity in Guided coNservative Management (SCAD-ALIGN) Trial

NCT07683923 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

3518

Enrollment

OTHER

Sponsor class

Conditions

SCAD
ACS (Acute Coronary Syndrome)

Interventions

DRUG: Acetylsalicylic acid ASA
DRUG: ASA plus Clopidogrel

Sponsor

Universitätsklinikum Hamburg-Eppendorf

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]